Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cannabis Misuse in MS Linked to Anxiety, Depression

Key clinical point: Providers should consider screening for hazardous cannabis use, especially if patients report depression, anxiety, or difficulty sleeping.

Major finding: Patients with MS who are depressed, anxious, or have poor sleep may be more likely to misuse or abuse cannabis.

Study details: 100 patients with a confirmed MS diagnosis who were receiving outpatient care in a university-affiliated MS center.

Disclosures: No study funding was reported and the authors report no relevant disclosures.

Citation:

REPORTING FROM CMSC 2019